Blood biomarkers for cognitive decline and clinical progression in a Mexican American cohort

Introduction: The clinical translation of biofluid markers for dementia requires validation in diverse cohorts. The study goal was to evaluate if blood biomarkers reflecting diverse pathophysiological processes predict disease progression in Mexican American adults. Methods: Mexican American adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzales, Mitzi M., Wang, Chen‐Pin, Short, Meghan I., Parent, Danielle M., Kautz, Tiffany, MacCarthy, Daniel, Satizabal, Claudia L., González, David Andrés, Royall, Donald R., Zare, Habil, O'Bryant, Sid, Maestre, Gladys E., Tracy, Russell P., Seshadri, Sudha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
BlOOD‐BASED BIOMARKERS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943903/
https://www.ncbi.nlm.nih.gov/pubmed/35356487
http://dx.doi.org/10.1002/dad2.12298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943903/
https://www.ncbi.nlm.nih.gov/pubmed/35356487
http://dx.doi.org/10.1002/dad2.12298

Ejemplares similares